On this page:
- About Tobacco Products, Addiction, and Quitting
- Tobacco’s Health Effects in Youth and Others
- Regulation, Compliance, and Enforcement
- Science and Research
Some feature article content, and other Center for Tobacco Product pieces of digital content, is available to embed on your website for free. Through content embedding/syndication, when content is updated on our site, it will automatically update on your site as well.
Please click the Embed This Content button on certain CTP web pages to add content to your website.
The Exchange Lab, run by the FDA Center for Tobacco Products, provides free print materials and web content aimed at communicating the dangers of tobacco use. In Exchange Lab, you can: Order and download print materials, embed digital/website content and download images to share on social media.
Nicotine is a highly addictive chemical compound present in the tobacco plant. Tobacco products, including cigarettes, cigars, smokeless tobacco, hookah tobacco, and most e-cigarettes, contain nicotine.
FDA is working on a comprehensive plan that places nicotine—and the issue of addiction—at the center of the agency’s tobacco regulation efforts.
As part of FDA's ongoing efforts to protect youth from the dangers of tobacco use, the agency is expanding its successful youth tobacco prevention campaign, “The Real Cost,” to reach the more than 10 million youth ages 12-17 who have used e-cigarettes or are open to trying them.
You probably know that cigarette smoking kills you. You probably know that cigarettes contain chemicals—a mix of over 7,000 chemicals, in fact—that can cause diseases including cancer, cardiovascular disease, and COPD.
What keeps people smoking even when they know cigarettes are harmful to their health? Nicotine. Nicotine, the highly addictive drug present in tobacco products, is the main reason that people continue to use tobacco even when they want to quit.
Though youth e-cigarette use is down from 2019, teen use remains alarmingly high. Learn the latest findings on the use of flavors, disposable e-cigarettes, and more.
E-cigarettes, including rechargeable batteries and e-liquid cartridges, can pose a threat to human health and to the environment if they are not disposed of properly.
Learn about the multidisciplinary work of CTP’s Office of Health Communication and Education from its Director, Kathy Crosby.
In 2018, FDA began a collaboration with Scholastic to create educational resources for teachers to address the e-cigarette epidemic in schools. Hear questions and answers about this collaboration from key players at FDA and Scholastic.
The science says they can. The nicotine in e-cigarettes can change the young brain and get kids hooked.
You probably know that tobacco use—particularly cigarette smoking—is harmful to health and can lead to premature death and disease, including, lung conditions, cardiovascular disease, and cancer nearly anywhere in the body.
While many Americans may know that smoking can cause cardiovascular disease and certain cancers, like lung cancer, they may not be aware that smoking can also negatively impact a woman’s reproductive health, as well as lead to cervical cancer.
Cigarette smoking in the United States is responsible for 480,000 deaths per year, and certain populations are more likely to smoke than others. One population especially at risk for engaging in tobacco use is the lesbian, gay, bisexual, transgender LGBT community.
According to a 2018 analysis of 2010-2015 data from the National Survey on Drug Use and Health, about 30 percent of veterans self-reported current (i.e., past 30-day) use of cigarettes, cigars, smokeless tobacco, roll-your-own, and/or pipe tobacco, with the majority of the users (21.6 percent) reporting current cigarette smoking.
Cigarette smoking is the chief cause of preventable disease and death in the United States and can harm nearly any part of the body.
You may be aware that cigarettes increase a person’s risk of cancer, as well as diseases of the heart, lungs, and other organs. But you might not know that smoking is a risk factor for type 2 diabetes.
Every organ in the human body serves an important purpose in keeping it running and in prime condition. Most healthy people are not cognizant of their organs—like lungs—on a daily basis, because they are able to breathe without difficulty and perform their daily tasks without major effort.
Learn about May Nelson’s contributions to improve public health through tobacco regulation.
Learn about the many types of opportunities available, our work culture, and the innovative ways that we recruit a diverse and qualified workforce.
FOIA and CTP: Protecting Citizens’ “Right to Know” by Fostering CTP Transparency
Learn about the mission and accomplishments of CTP’s Office of Compliance and Enforcement from its Director, Ann Simoneau.
Here, we introduce you to the Center for Tobacco Products’ Office of Small Business Assistance (OSBA), the resources it offers, and how you can reach out for help with more specific questions.
On October 22, 2019, FDA granted the first-ever modified risk orders to Swedish Match USA, Inc. for eight snus smokeless tobacco products.
FDA has proposed new health warnings for cigarette packages and advertisements that would include text statements, accompanied by photo-realistic color images, to promote greater public understanding of the negative health consequences of smoking.
In response to industry feedback, FDA’s Center for Tobacco Products (CTP) has updated its electronic document submission system—including the eSubmitter software—to assist manufacturers of deemed tobacco products with navigating the ingredient listing submission process and other online submissions in a quicker and more efficient way.
While there are three main ways to bring a new tobacco product to market, a premarket tobacco application (PMTA) is the most likely pathway by which manufacturers of e-cigarettes and other electronic nicotine delivery systems (ENDS) will apply to market their products.
Matt Holman, Ph.D., Director of the FDA’s Center for Tobacco Products’ (CTP) Office of Science, has over 17 years of experience working as a regulatory scientist, getting his start at FDA in the Center for Drug Evaluation and Research (CDER).
A Conversation with Karen Cullen, Ph.D., A Scientist at the FDA’s Center for Tobacco Products Who Leads the National Youth Tobacco Survey.
The PATH Study strives to better understand what motivates youth and young adults to use tobacco.